Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1110173

registered interest
date	08/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dermatology: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment the Government has made of the quality of (a) undergraduate level and (b) specialist general practice dermatology training.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	242084
answer	answer is ministerial correction date of answer 12/04/2019 answer text <p>Each individual medical school sets its own undergraduate medical curriculum. These have to meet the standards set by the General Medical Council (GMC) in ‘Promoting excellence’, who then monitor and check to make sure that these standards are maintained. The curricula for postgraduate specialty training is set by individual royal colleges and faculties, and the GMC approves curricula and assessment systems for each training programme.</p><p> </p><p>There are no specific medical dermatology undergraduate training pathways, as all medical students complete a medical degree and foundation training to the point of GMC registration, and then students can specialise in dermatology as part of a postgraduate core medical training and higher specialty training programme. Dermatology is one of 30 specialties within the medicine specialty group. It is a highly competitive specialty and often oversubscribed.</p><p> </p><p>The number of medical specialty training places in England that are available each year is set by Health Education England and is based on their assessment of service gaps and predicted workforce needs. There has been a 100% fill rate in dermatology training in England for the past six years.</p><p> </p><p>Dermatologist education and training and recruitment in Wales, Northern Ireland and Scotland is a matter for the devolved administrations.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 12/04/2019 13:56:35 answering member 1585 label Biography information for Stephen Hammond
tabling member	3928 label Biography information for Nick Smith

1109979

registered interest
date	05/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dermatology: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has for proposals to improve waiting times for dermatology patients.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	241419
answer	answer is ministerial correction date of answer 12/04/2019 answer text <p>Clinical commissioning groups are putting in place initiatives to help better manage the increasing demand for dermatology services. This has included developing clear multidisciplinary pathways and care models that address patients’ physical and psychological needs, better use of teledermatology as well as a clear model for community dermatology; using nurses, pharmacists and general practitioners with extended roles to ensure that patients receive the right treatment and care in the most appropriate setting.</p><p> </p><p>The National Health Service has worked with local sites and published a handbook that describes what local health and care systems can do to transform dermatology elective care services at pace, why this is necessary and how the impact of this transformation can be measured. Practical guidance for implementing and adopting a range of interventions locally is included to help ensure patients see the right person, in the right place, first time.</p><p> </p><p>The dermatology handbook can be found on the NHS England website at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/01/dermatology-elective-care-handbook-v1.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/01/dermatology-elective-care-handbook-v1.pdf</a></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 12/04/2019 13:58:19 answering member 1585 label Biography information for Stephen Hammond
tabling member	3928 label Biography information for Nick Smith

1105284

registered interest
date	26/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the merits of raising the current clinical age limits for screening for (a) breast and (b) cervical cancer.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	237076
answer	answer is ministerial correction date of answer 02/04/2019 answer text <p>In response to the Independent Breast Screening Review 2018, the United Kingdom National Screening Committee (UK NSC) has commissioned work to help clarify what the upper screening age in breast should be and discussed the findings at its meeting in February. The recommendation will be made to Ministers and minutes of the UK NSC meeting will be made available six weeks after the meeting at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc" target="_blank">https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc</a></p><p> </p><p>We continue to wait for the results of the Age Extension Trial to help provide the evidence needed to better understand what the benefits and harms are when offering screening outside the current recommended screening age.</p><p> </p><p>Regarding the age for cervical screening, women will stop receiving routine invitations once they reach 65 unless they need ongoing surveillance or follow up. The natural history of cervical cancer means that it is unlikely that women over this age who have been regularly screened will go on to develop cervical cancer; furthermore, we know that screening becomes more uncomfortable for women as the cervix is less visible after menopause.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 02/04/2019 15:44:22 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	3928 label Biography information for Nick Smith

1105285

registered interest
date	26/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Child Measurement Programme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the merits of extending the National Child Measurement Programme to other primary school age groups.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	237077
answer	answer is ministerial correction date of answer 03/04/2019 answer text <p>I refer the hon. Member to the answer given by the former Parliamentary Under-Secretary of State for Public Health and Primary Care (Steve Brine MP) to the hon. Member for Liverpool, Wavertree (Luciana Berger MP) on 7 February 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-02-04/216349/" target="_blank">216349</a>.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 03/04/2019 11:22:35 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	3928 label Biography information for Nick Smith

1077662

registered interest
date	26/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to his oral Answer of 19 February 2019, Official Report, column 1315, on Leaving the EU: Contingency Planning, how his Department calculated the estimated cost of NHS no-deal contingency plans.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	226083
answer	answer is ministerial correction date of answer 06/03/2019 answer text <p>The £11 million (approximate) figure quoted by my Rt. hon. Friend the Secretary of State for Health and Social Care, refers to the costs of the contracts the Department has signed with warehouse providers to provide storage facilities to stockpile medicines in case of the United Kingdom leaving the European Union without a deal on 29 March 2019.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 06/03/2019 10:59:22 answering member 1585 label Biography information for Stephen Hammond
tabling member	3928 label Biography information for Nick Smith

1052504

registered interest
date	01/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 January 2019 to Question 205244 on Drugs: Refrigerators, how many refrigerators his Department has purchased as part of contingency planning for the UK leaving the EU to date.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	215569
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>As part of the Department’s ‘no deal’ European Union exit contingency planning contract agreements have been signed for the provision of storage. The contracts include capacity for 5,000 pallets of refrigerated warehouse storage.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 08/02/2019 12:50:15 answering member 1585 label Biography information for Stephen Hammond
tabling member	3928 label Biography information for Nick Smith

1045494

registered interest
date	21/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 January 2019 to Question 205247 on Drugs: refrigerators, what proportion of the (a) ambient storage pallets, (b) refrigerated storage pallets and (c) controlled drug storage pallets purchased as part of the Department's contingency planning in the event of the UK leaving the EU without a deal were manufactured in the UK.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	210498
answer	answer is ministerial correction date of answer 29/01/2019 answer text <p>The Department’s contingency planning is to ask industry to stockpile an additional six weeks’ supply of prescription-only and pharmacy medicines which come to the United Kingdom from or via the European Union/European Economic Area, over and above usual buffer stocks. No medicines or pallets have been purchased as part of the contingency planning.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 29/01/2019 17:12:16 answering member 1585 label Biography information for Stephen Hammond
tabling member	3928 label Biography information for Nick Smith

1035219

registered interest
date	04/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the locations at which the refrigerators purchased by his Department for the preservation of medicines as part of contingency planning in the event the UK leaves the EU without a deal will be stored.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	205242
answer	answer is ministerial correction date of answer 11/01/2019 answer text <p>As part of the Department’s ‘no deal’ European Union exit contingency planning, a tender process to procure additional warehouse space built in the mainland United Kingdom to store stockpiled medicines, including ambient, refrigerated and controlled drug storage, was undertaken in October 2018. Contract agreements for storage have recently been signed or will be signed imminently. This is expected to cost the Government in the low tens of millions of pounds with the refrigerated storage expected to cost circa £1 million.</p><p> </p><p>The contracts will cover additional capacity including 53,000 pallets of ambient storage, 5,000 pallets of refrigerated storage and 850 pallets of controlled drug storage. We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019, lasting for a period of between 12 and 18 months. For security reasons the locations of the additional warehouse capacity will not be published.</p><p> </p><p>The Department’s funding for additional warehouse capacity is on the condition that it is exclusively for the storage of additional stockpiles of prescription only and pharmacy medicines that come into the UK from or via the EU. The Department recognises that through our ‘no deal’ EU exit medicines contingency programme. We are requesting sensitive commercial information from pharmaceutical suppliers. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about specific medicines into the public domain.</p><p> </p><p>As with many contracts involving capital investment, the Department will be liable for some capital costs already incurred by the contractors in the event of a deal being approved by parliament. In that scenario, warehouse providers are required to decommission the additional capacity. The Department has also put in place measures to minimise pre-committed expenditure in the event of a deal being achieved.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 205243 205244 205245 205246 205247 205248 205249 205250 question first answered 11/01/2019 12:13:04 answering member 1585 label Biography information for Stephen Hammond
tabling member	3928 label Biography information for Nick Smith

1035290

registered interest
date	04/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many refrigerators his Department plans to purchase for each forthcoming calendar month as part of contingency planning in the event of the UK leaving the EU without a deal.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	205243
answer	answer is ministerial correction date of answer 11/01/2019 answer text <p>As part of the Department’s ‘no deal’ European Union exit contingency planning, a tender process to procure additional warehouse space built in the mainland United Kingdom to store stockpiled medicines, including ambient, refrigerated and controlled drug storage, was undertaken in October 2018. Contract agreements for storage have recently been signed or will be signed imminently. This is expected to cost the Government in the low tens of millions of pounds with the refrigerated storage expected to cost circa £1 million.</p><p> </p><p>The contracts will cover additional capacity including 53,000 pallets of ambient storage, 5,000 pallets of refrigerated storage and 850 pallets of controlled drug storage. We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019, lasting for a period of between 12 and 18 months. For security reasons the locations of the additional warehouse capacity will not be published.</p><p> </p><p>The Department’s funding for additional warehouse capacity is on the condition that it is exclusively for the storage of additional stockpiles of prescription only and pharmacy medicines that come into the UK from or via the EU. The Department recognises that through our ‘no deal’ EU exit medicines contingency programme. We are requesting sensitive commercial information from pharmaceutical suppliers. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about specific medicines into the public domain.</p><p> </p><p>As with many contracts involving capital investment, the Department will be liable for some capital costs already incurred by the contractors in the event of a deal being approved by parliament. In that scenario, warehouse providers are required to decommission the additional capacity. The Department has also put in place measures to minimise pre-committed expenditure in the event of a deal being achieved.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 205242 205244 205245 205246 205247 205248 205249 205250 question first answered 11/01/2019 12:13:04 answering member 1585 label Biography information for Stephen Hammond
tabling member	3928 label Biography information for Nick Smith

1035291

registered interest
date	04/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the cost to the public purse of purchasing refrigerators for the preservation of medicines as part of contingency planning for the event of the UK leaving the EU without a deal.
tabling member constituency	Blaenau Gwent
tabling member printed	Nick Smith
uin	205244
answer	answer is ministerial correction date of answer 11/01/2019 answer text <p>As part of the Department’s ‘no deal’ European Union exit contingency planning, a tender process to procure additional warehouse space built in the mainland United Kingdom to store stockpiled medicines, including ambient, refrigerated and controlled drug storage, was undertaken in October 2018. Contract agreements for storage have recently been signed or will be signed imminently. This is expected to cost the Government in the low tens of millions of pounds with the refrigerated storage expected to cost circa £1 million.</p><p> </p><p>The contracts will cover additional capacity including 53,000 pallets of ambient storage, 5,000 pallets of refrigerated storage and 850 pallets of controlled drug storage. We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019, lasting for a period of between 12 and 18 months. For security reasons the locations of the additional warehouse capacity will not be published.</p><p> </p><p>The Department’s funding for additional warehouse capacity is on the condition that it is exclusively for the storage of additional stockpiles of prescription only and pharmacy medicines that come into the UK from or via the EU. The Department recognises that through our ‘no deal’ EU exit medicines contingency programme. We are requesting sensitive commercial information from pharmaceutical suppliers. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about specific medicines into the public domain.</p><p> </p><p>As with many contracts involving capital investment, the Department will be liable for some capital costs already incurred by the contractors in the event of a deal being approved by parliament. In that scenario, warehouse providers are required to decommission the additional capacity. The Department has also put in place measures to minimise pre-committed expenditure in the event of a deal being achieved.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 205242 205243 205245 205246 205247 205248 205249 205250 question first answered 11/01/2019 12:13:04 answering member 1585 label Biography information for Stephen Hammond
tabling member	3928 label Biography information for Nick Smith